cytarabine and Histiocytosis, Langerhans-Cell

cytarabine has been researched along with Histiocytosis, Langerhans-Cell in 51 studies

Research

Studies (51)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (9.80)	18.2507
2000's	10 (19.61)	29.6817
2010's	22 (43.14)	24.3611
2020's	14 (27.45)	2.80

Authors

Authors	Studies
Cai, H; Cai, HC; Cao, XX; Chen, J; Duan, MH; Gao, XM; Li, J; Liang, ZY; Liu, T; Sun, J; Zhang, L; Zhao, AL; Zhou, DB	1
Cai, H; Cai, HC; Cao, XX; Chen, M; Li, J; Liu, T; Zhang, W; Zhou, DB	1
DU, Y; Li, H; Li, JX; Lu, WJ; Qi, SS; Tao, F; Xiong, H; Yang, L; Zhang, LN	1
Bernhardt, MB; Eckstein, OS; Hood, CG; Karri, V; Kralik, SF; McClain, KL	1
Imamura, T; Kanegane, H; Koh, K; Kosaka, Y; Kudo, K; Morimoto, A; Nakazawa, A; Nakazawa, Y; Saito, AM; Shioda, Y; Watanabe, T; Yuza, Y	1
Baidildina, D; Bronin, G; Burtsev, E; Cherniak, E; Dzhukaeva, I; Erega, E; Evseev, D; Fink, O; Ignatova, A; Kalinina, I; Kotskaya, N; Litvin, E; Lyudovskikh, E; Maschan, A; Maschan, M; Novichkova, G; Osipova, D; Popov, A; Pristanskova, E; Purbueva, B; Raykina, E; Semchenkova, A; Vlasova, I; Voronin, K; Zhogov, V	1
Donadieu, J	1
Gershman, G; Getachew, R; Gotesman, M; Lasky, JL; Lee, S; Morales, S; Panosyan, EH; Zangwill, KM	1
Azuma, Y; Fukano, R; Hasegawa, S; Ichimura, T; Iida, Y; Ohga, S; Yasudo, H	1
Cai, HC; Cao, XX; Duan, MH; Feng, J; Gao, XM; He, TH; Li, J; Liang, ZY; Niu, N; Sun, J; Zhang, L; Zhang, Y; Zhao, AL; Zhou, DB; Zhu, TN	1
Duan, M; Han, X; Li, J; Ouyang, M; Wang, S; Zhang, W; Zhou, D; Zhu, T	1
Aguirre, LE; Alencar, A; Chapman, J; Larsen, MF; Schwartz, I	1
Imamura, T; Imashuku, S; Morimoto, A; Sakamoto, K; Shioda, Y	1
Gulati, N	1
Fares, E; Maddah, J; Mansour, MJ; Mokbel, E; Nasr, F	1
Aleem, E; Arceci, RJ; Azorsa, DO; Bista, R; Henry, MM; Lee, DW; Patel, AR; Wai, DH	1
Chang Liao, NF; Lin, TY; Shen, WC; Wu, PY	1
Halperson, E; Weintraub, M	1
Bingen, K; Donohoue, PA; Ehrhardt, MJ; Karst, J; Kelly, ME; Maheshwari, M; McClain, KL	1
Allen, CE; Ladisch, S; McClain, KL	1
Amaral, D; Braier, JL; Chantada, G; Latella, A; Rosso, DA	1
Arico, M; Armari Alla, C; Bardet, O; Barkaoui, M; Bernard, F; Clausen, N; Donadieu, J; Gandemer, V; Henter, JI; Jeziorski, E; Lambilliote, A; Mura, R; Piguet, C; Van Den Bos, C; van Noesel, M; Weitzman, S	1
Stine, KC	1
Bessho, F; Fujimoto, J; Horibe, K; Imamura, T; Imashuku, S; Ishii, E; Kawaguchi, H; Kobayashi, R; Koga, Y; Kudo, K; Morimoto, A; Sakashita, K; Shioda, Y; Tsunematsu, Y; Yasui, M	1
Hazeki, D; Imamura, M; Kawakami, K; Kawano, Y; Nakagawa, S; Okamoto, Y; Shinkoda, Y	1
Bakane, A; Balaji, R; Raj, R; Ramachandrakurup, S; Subburaj, D; Uppuluri, R	1
Argenyi, Z; Hurst, S; Olerud, J; Tran, DT; Wolgamot, GM	1
Apollonsky, N; Lipton, JM	1
Abadjian, GA; Aftimos, PG; El Karak, FR; Ghosn, MG; Haddad, AC; Nassar, MN	1
Allen, CE; Dauser, R; Flores, R; Goldman, S; Hetherington, M; Hsu, DA; McClain, KL; Murray, JC; Puccetti, D; Rauch, R; Sondel, P	1
Imamura, T; Imashuku, S; Morimoto, A; Shioda, Y; Tsunematsu, Y	1
Imamura, T; Kamizono, J; Kanegane, H; Kudo, K; Morimoto, A; Nakadate, H; Nakagawa, S; Sato, T; Shiota, Y; Tauchi, H	1
Aghakhani, R; Alavi, S; Arzanian, MT; Gharib, A; Goudarzipour, K; Jadali, F; Rezaei, N; Shamsian, BS	1
Berkow, RL; Cook, R; Friedman, GK; Kelly, DR	1
Dib, M; Gagnadoux, F; Paris, A; Rousselet, MC; Tazi, A; Urban, T	1
Adam, Z; Adamová, Z; Brejcha, M; Hájek, R; Kodet, R; Koukalová, R; Krejčí, M; Mayer, J; Moulis, M; Nebeský, T; Pour, L; Rehák, Z; Szturz, P; Zahradová, L	1
Bowler, S; Burr, L; Fanning, S; Wong, D	1
Hwang, YY; Kwong, YL; Leung, RY; Tsui, P	1
Bangaru, BS; Choi, SW; Finlay, JL; Wu, CD	1
McClain, KL	1
Bernard, F; Bertrand, Y; Chastagner, P; Colin, VM; Donadieu, J; Landman Parker, J; Munzer, M; Ouache, M; Perel, Y; Thomas, C; Vermylen, C	1
Herring, RA; Lee, DA; McClain, KL; Tatevian, N	1
Fujimoto, J; Imai, K; Kanegane, H; Kogawa, K; Nonoyama, S; Tsuji, Y	1
Boyle, IT; Forrest, E; Gallacher, SJ; Hadley, D; Soukop, M	1
de Kraker, J; Egeler, RM; Voûte, PA	2
Aricò, M; Bossi, G; Comelli, A; Egeler, RM; Piombo, M; Raiteri, E	1
Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N	1
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A	1
Brito, G; Fernandez, T; Klumb, C; Land, MG; Maradei, S; Otero, L; Pombo-de-Oliveira, MS; Silva, ML; Veith, M	1
Egeler, RM; Heymans, HS; Schipper, ME	1

Reviews

6 review(s) available for cytarabine and Histiocytosis, Langerhans-Cell

Article	Year
A Case of Langerhans Cell Histiocytosis With Multifocal, Single-System GI Tract Involvement and Literature Review. Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:6 Topics: Adult; Antimetabolites, Antineoplastic; Cytarabine; Female; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Prognosis; Young Adult	2020
Drug therapy for the treatment of Langerhans cell histiocytosis. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Anti-Inflammatory Agents; Antimetabolites; Brain Diseases; Cell Proliferation; Cladribine; Cytarabine; Drug Therapy, Combination; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Mercaptopurine; Practice Guidelines as Topic; Prednisone; Randomized Controlled Trials as Topic; Risk Factors; Secondary Prevention; Thalidomide; Vinblastine	2005
Central nervous system histiocytosis X--imaging and responses to chemotherapy. Scottish medical journal, 1993, Volume: 38, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Injections, Spinal; Magnetic Resonance Imaging; Male; Methotrexate	1993
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine	2001
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine	2001
Gastrointestinal involvement in Langerhans' cell histiocytosis (Histiocytosis X): a clinical report of three cases. European journal of pediatrics, 1990, Volume: 149, Issue:5 Topics: Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Prednisone; Vincristine	1990

Trials

5 trial(s) available for cytarabine and Histiocytosis, Langerhans-Cell

Article	Year
Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study. International journal of hematology, 2023, Volume: 118, Issue:1 Topics: Antineoplastic Agents; Child; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Retrospective Studies; Treatment Outcome; Vincristine	2023
Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study. American journal of hematology, 2020, Volume: 95, Issue:9 Topics: Adolescent; Adult; Aged; Cytarabine; Disease-Free Survival; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Cell; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Survival Rate	2020
The combination of methotrexate and cytosine arabinoside in newly diagnosed adult Langerhans cell histiocytosis: a prospective phase II interventional clinical trial. BMC cancer, 2020, May-18, Volume: 20, Issue:1 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Early Medical Intervention; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Young Adult	2020
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. Blood, 2015, Sep-17, Volume: 126, Issue:12 Topics: Antineoplastic Agents; Child, Preschool; Cladribine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Langerhans Cells; Liver; Male; Recurrence; Spleen; Survival Analysis; Survival Rate; Vinblastine	2015
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Medical and pediatric oncology, 1993, Volume: 21, Issue:4 Topics: Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Male; Prednisolone; Remission Induction; Treatment Outcome; Vincristine	1993

Other Studies

40 other study(ies) available for cytarabine and Histiocytosis, Langerhans-Cell

Article	Year
Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. American journal of hematology, 2022, 02-01, Volume: 97, Issue:2 Topics: Adult; Aged; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult	2022
Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis. Orphanet journal of rare diseases, 2022, 02-07, Volume: 17, Issue:1 Topics: Cytarabine; Erdheim-Chester Disease; Histiocytosis, Langerhans-Cell; Histiocytosis, Sinus; Humans; Neutropenia	2022
[Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine]. Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:3 Topics: Child; Cladribine; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Recurrence; Retrospective Studies	2022
Treatment of Langerhans cell histiocytosis with subcutaneous cytarabine. Pediatric hematology and oncology, 2023, Volume: 40, Issue:5 Topics: Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Magnetic Resonance Imaging; Remission Induction; Skin Neoplasms	2023
Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E-positive LCH. Blood advances, 2023, 09-26, Volume: 7, Issue:18 Topics: Child; Cladribine; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Neoplasm Recurrence, Local; Proto-Oncogene Proteins B-raf; Vemurafenib	2023
Comment on "Subcutaneous administration of cytarabine for pediatric patients with Langerhans cell histiocytosis decreases burden of patient travel and infusion center utilization". Pediatric blood & cancer, 2023, Volume: 70, Issue:11 Topics: Child; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Travel	2023
Surge of serum interleukin-2 level in a Japanese patient with cytarabine syndrome. Pediatric blood & cancer, 2020, Volume: 67, Issue:3 Topics: Antimetabolites, Antineoplastic; Cytarabine; Cytokine Release Syndrome; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Interleukin-2; Prognosis	2020
Adult Langerhans cell histiocytosis presenting with multisystem involvement and sarcomatoid features: a case report. Journal of medical case reports, 2020, Sep-27, Volume: 14, Issue:1 Topics: Adult; Child; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Male; Prognosis; Sarcoma; Soft Tissue Neoplasms	2020
Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies. British journal of haematology, 2021, Volume: 192, Issue:3 Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male	2021
The global challenge of treating disseminated LCH. Pediatric hematology and oncology, 2020, Volume: 37, Issue:8 Topics: Antineoplastic Agents; Child; Cladribine; Clofarabine; Cytarabine; Disease Management; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Pediatrics; Protein Kinase Inhibitors	2020
Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report. Journal of medical case reports, 2017, Sep-25, Volume: 11, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Diseases; Colonic Diseases; Colonoscopy; Cytarabine; Disease Progression; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Male; Prednisone; Rectal Diseases; Tomography, X-Ray Computed; Vinblastine	2017
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis. Pediatric blood & cancer, 2018, Volume: 65, Issue:9 Topics: Adolescent; Adrenal Cortex Hormones; Butadienes; Combined Modality Therapy; Cytarabine; Disease Progression; Drug Resistance; Drug Therapy, Combination; Enzyme Activation; Exons; HEK293 Cells; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Molecular Targeted Therapy; Mutation; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyridones; Pyrimidinones; Recombinant Fusion Proteins; Sequence Deletion; Thiophenes; Vincristine	2018
Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report. Journal of cutaneous pathology, 2019, Volume: 46, Issue:1 Topics: Adult; Cytarabine; Female; Head and Neck Neoplasms; Histiocytosis, Langerhans-Cell; Histiocytosis, Non-Langerhans-Cell; Humans; Skin Neoplasms; Skull Neoplasms	2019
Oral Langerhans Cell Histiocytosis in an Infant. Journal of dentistry for children (Chicago, Ill.), 2018, May-15, Volume: 85, Issue:2 Topics: Cytarabine; Drug Therapy, Combination; Follow-Up Studies; Glass Ionomer Cements; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male; Mercaptopurine; Methotrexate; Mouth Diseases; Prednisone; Vinblastine	2018
Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report. Journal of pediatric hematology/oncology, 2015, Volume: 37, Issue:1 Topics: Child; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases	2015
How I treat Langerhans cell histiocytosis. Blood, 2015, Jul-02, Volume: 126, Issue:1 Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Clofarabine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Lung Diseases; Male; Middle Aged; Remission Induction; Skin Diseases; Thoracic Surgery, Video-Assisted; Vaginal Diseases	2015
Reduced doses of cladribine and cytarabine regimen was effective and well tolerated in patients with refractory-risk multisystem Langerhans cell histiocytosis. British journal of haematology, 2016, Volume: 172, Issue:2 Topics: Cladribine; Cytarabine; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Retrospective Studies; Salvage Therapy	2016
Risk organ + LCH gets the one-two punch? Blood, 2015, Sep-17, Volume: 126, Issue:12 Topics: Antineoplastic Agents; Cladribine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male	2015
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study. International journal of hematology, 2016, Volume: 104, Issue:1 Topics: Adolescent; Child; Child, Preschool; Clinical Protocols; Cyclosporine; Cytarabine; Disease-Free Survival; Drug Therapy, Combination; Histiocytosis, Langerhans-Cell; Humans; Multiple Organ Failure; Prednisolone; Remission Induction; Time Factors; Treatment Outcome; Vincristine	2016
Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis. Journal of pediatric endocrinology & metabolism : JPEM, 2016, Jul-01, Volume: 29, Issue:7 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Diabetes Insipidus, Neurogenic; Female; Histiocytosis, Langerhans-Cell; Humans; Japan; Magnetic Resonance Imaging; Organ Size; Pituitary Gland; Recurrence; Treatment Outcome	2016
Successful Treatment of Refractory Langerhans Cell Histiocytosis of the Choroid Plexus in a Child With Pulse Dexamethasone and Lenalidomide. Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:2 Topics: Choroid Plexus; Cladribine; Cytarabine; Dexamethasone; Diabetes Insipidus; Drug Resistance; Histiocytosis, Langerhans-Cell; Humans; Infant; Lenalidomide; Male; Pituitary Gland, Posterior; Prednisolone; Pulse Therapy, Drug; Remission Induction; Salvage Therapy; Skull Base; Thalidomide; Thoracic Vertebrae; Vinblastine	2017
An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis. Journal of cutaneous pathology, 2008, Volume: 35 Suppl 1 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Methotrexate; Prednisone; Vincristine; Xanthogranuloma, Juvenile	2008
Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cladribine; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Radiography; Recurrence; Survival Rate	2009
Acute myeloid leukemia and Langerhans' cell histiocytosis: multiple theories for an unusual presentation. Leukemia research, 2010, Volume: 34, Issue:3 Topics: Aged, 80 and over; Antineoplastic Agents; Chromosomes, Human, Pair 8; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Trisomy	2010
Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside. Pediatric blood & cancer, 2010, Volume: 54, Issue:3 Topics: Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Hydrocephalus; Infant; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Retrospective Studies; Vincristine	2010
VCR/AraC chemotherapy and ND-CNS-LCH. Pediatric blood & cancer, 2010, Jul-15, Volume: 55, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Infant; Neurodegenerative Diseases; Vincristine	2010
Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan. International journal of hematology, 2010, Volume: 91, Issue:4 Topics: 2-Chloroadenosine; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Data Collection; Deoxyadenosines; Drug Resistance, Neoplasm; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Infant, Newborn; Japan; Male; Surveys and Questionnaires; Treatment Outcome	2010
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma. Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisolone; Prednisone; Vinblastine; Vincristine	2010
Long-term complete response after treatment with cytarabine, vincristine, and prednisone in an infant with refractory multisystem Langerhans cell histiocytosis. Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Prednisolone; Remission Induction; Vincristine	2011
[Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma]. Revue des maladies respiratoires, 2011, Volume: 28, Issue:7 Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bronchioles; Carmustine; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Ifosfamide; Incidental Findings; Lung Diseases; Lymphatic Diseases; Marijuana Smoking; Melphalan; Methylprednisolone; Mitoguazone; Remission Induction; Smoking; Tomography, X-Ray Computed; Vinblastine; Vindesine; Vinorelbine; Young Adult	2011
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transp Vnitrni lekarstvi, 2012, Volume: 58, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cladribine; Combined Modality Therapy; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Histiocytosis, Langerhans-Cell; Humans; Lenalidomide; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Recurrence; Remission Induction; Thalidomide; Transplantation, Autologous	2012
An unusual radiological presentation of pulmonary Langerhans' cell histiocytosis. BMJ case reports, 2012, Jul-03, Volume: 2012 Topics: Aged; Antimetabolites, Antineoplastic; Cytarabine; Exanthema; Female; Histiocytosis, Langerhans-Cell; Humans; Lung Diseases; Radiography	2012
Disseminated Langerhans cell histiocytosis associated with acute myeloid leukaemia: complete remission with daunorubicin and cytarabine. Annals of hematology, 2013, Volume: 92, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Histiocytosis, Langerhans-Cell; Humans; Leukemia, Myeloid, Acute; Lymph Nodes; Male; Palatine Tonsil; Remission Induction	2013
Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:6 Topics: Biopsy; Cladribine; Cytarabine; Drug Therapy, Combination; Gastrointestinal Diseases; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male	2003
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:17 Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Cytarabine; Drug Therapy, Combination; Female; Hematologic Diseases; Histiocytosis, Langerhans-Cell; Humans; Infant; Infusions, Intravenous; Male; Pilot Projects; Survival Analysis	2005
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH. Pediatric blood & cancer, 2008, Volume: 50, Issue:3 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Doxorubicin; Drug Therapy, Combination; Epstein-Barr Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunocompromised Host; Infant; Lymphoma, Large B-Cell, Diffuse; Mercaptopurine; Methotrexate; Mycoses; Prednisone; Recurrence; Rituximab; Vinblastine; Vincristine; Virus Activation	2008
Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH. International journal of hematology, 2008, Volume: 87, Issue:1 Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Cytokines; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Prednisolone; Remission Induction; Syndrome; Vincristine	2008
Langerhans cell histiocytosis and acute leukemia: unusual association in two cases. Medical and pediatric oncology, 1993, Volume: 21, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Histiocytosis, Langerhans-Cell; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Male; Prednisolone; Vinblastine; Vincristine	1993
[Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988]. Nederlands tijdschrift voor geneeskunde, 1993, May-08, Volume: 137, Issue:19 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Drug Therapy, Combination; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Outcome Assessment, Health Care; Prednisone; Prognosis; Vincristine	1993
Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis. Cancer genetics and cytogenetics, 2002, Volume: 135, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Cytarabine; Drug Therapy, Combination; Enzyme Inhibitors; Etoposide; Fatal Outcome; Histiocytosis, Langerhans-Cell; Humans; Idarubicin; Karyotyping; Leukemia, Myelomonocytic, Acute; Male; Neoplasms, Second Primary; Nuclear Pore Complex Proteins; Prednisolone; Topoisomerase II Inhibitors; Translocation, Genetic; Vinblastine	2002